Page 1924 - Williams Hematology ( PDFDrive )

1898 Part XII: Hemostasis and Thrombosis Chapter 112: Platelet Morphology, Biochemistry, and Function 1899

871. Zhu J, et al: The structure of a receptor with two associating transmembrane domains 905. Calderwood DA, et al: The talin head domain binds to integrin beta subunit cytoplas-
on the cell surface: Integrin alphaIIbbeta3. Mol Cell 34(2):234–249, 2009. mic tails and regulates integrin activation. J Biol Chem 274:28071–28074, 1999.
872. Kim M, Carman CV, Springer TA: Bidirectional transmembrane signaling by cyto- 906. Cowan KJ, Law DA, Phillips DR: Identification of shc as the primary protein binding
plasmic domain separation in integrins. Science 301(5640):1720–1725, 2003. to the tyrosine-phosphorylated beta 3 subunit of alpha IIbbeta 3 during outside-in
873. Li W, et al: A push-pull mechanism for regulating integrin function. Proc Natl Acad Sci integrin platelet signaling. J Biol Chem 275(46):36423–36429, 2000.
U S A 102(5):1424–1429, 2005. 907. Eigenthaler M, et al: A conserved sequence motif in the integrin beta3 cytoplasmic
874. Luo BH, et al: Disrupting integrin transmembrane domain heterodimerization domain is required for its specific interaction with beta3-endonexin. J Biol Chem
increases ligand binding affinity, not valency or clustering. Proc Natl Acad Sci U S A 272(12):7693–7698, 1997.
102(10):3679–3684, 2005. 908. Hannigan GE, et al: Regulation of cell adhesion and anchorage-dependent growth by
875. Partridge AW, et al: Transmembrane domain helix packing stabilizes integrin a new beta 1-integrin-linked protein kinase. Nature 379(6560):91–96, 1996.
alphaIIbbeta3 in the low affinity state. J Biol Chem 280(8):7294–7300, 2005. 909. Loh E, Qi W, Vilaire G, Bennett JS: Effect of cytoplasmic domain mutations on the
876. Leisner TM, et al: Bidirectional transmembrane modulation of integrin alphaIIbbeta3 agonist-stimulated ligand binding activity of the platelet integrin alphaIIbbeta3. J Biol
conformations. J Biol Chem 274(18):12945–12949, 1999. Chem 271(47):30233–30241, 1966.
877. Vinogradova O, et al: A Structural mechanism of integrin alpha(IIb)beta(3) “inside- 910. Law DA, Nannizzi-Alaimo L, Phillips DR: Outside-in integrin signal transduction.
out” activation as regulated by its cytoplasmic face. Cell 110(5):587. Alpha IIb beta 3-(GP IIb IIIa) tyrosine phosphorylation induced by platelet aggrega-
878. Xiong JP, Stehle T, Goodman SL, Arnaout MA: A novel adaptation of the integrin tion. J Biol Chem 271(18):10811–10815, 1996.
PSI domain revealed from its crystal structure. J Biol Chem 279(39):40252–40254, 911. Leung-Hagesteijn CY, et al: Cell attachment to extracellular matrix substrates is
2004. inhibited upon downregulation of expression of calreticulin, an intracellular integrin
879. Du X, et al: Long range propagation of conformational changes in integrin alpha IIb alpha-subunit-binding protein. J Cell Sci 107(Pt 3):589–600, 1994.
beta 3. J Biol Chem 268(31):23087–23092, 1993 [published erratum appears in J Biol 912. Naik UP, Patel PM, Parise LV: Identification of a novel calcium-binding protein
Chem 269(15):11673, 1994]. that interacts with the integrin alphaIIb cytoplasmic domain. J Biol Chem 272(8):
880. Frelinger AL 3ed, Du XP, Plow EF, Ginsberg MH: Monoclonal antibodies to lig- 4651–4654, 1997.
and-occupied conformers of integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) alter 913. Otey CA, Pavalko FM, Burridge K: An interaction between alpha-actinin and the beta
receptor affinity, specificity, and function. J Biol Chem 266:17106–17111, 1991. 1 integrin subunit in vitro. J Cell Biol 111(2):721–729, 1990.
881. Kamata T, et al: Critical cysteine residues for regulation of integrin alphaIIbbeta3 are 914. Reddy KB, et al: Identification of an interaction between the m-band protein skelemin
clustered in the epidermal growth factor domains of the beta3 subunit. Biochem J and beta-integrin subunits. Colocalization of a skelemin-like protein with beta1- and
378(Pt 3):1079–1082, 2004. beta3-integrins in non-muscle cells. J Biol Chem 273(52):35039–35047, 1998.
882. Kashiwagi H, et al: A mutation in the extracellular cysteine-rich repeat region of 915. Rojiani MV, et al: In vitro interaction of a polypeptide homologous to human Ro/SS-A
the beta3 subunit activates integrins alphaIIbbeta3 and alphaVbeta3. Blood 93(8): antigen (calreticulin) with a highly conserved amino acid sequence in the cytoplasmic
2559–2568, 1999. domain of integrin alpha subunits. Biochemistry 30(41):9859–9866, 1991.
883. Essex DW: The role of thiols and disulfides in platelet function. Antioxid Redox Signal 916. Schaller MD, et al: Focal adhesion kinase and paxillin bind to peptides mimicking
6(4):736–746, 2004. beta integrin cytoplasmic domains. J Cell Biol 130(5):1181–1187, 1995.
884. Zucker MB, Masiello NC: Platelet aggregation caused by dithiothreitol. Thromb 917. Shattil SJ, et al: Beta 3-endonexin, a novel polypeptide that interacts specifically with
Haemost 51(1):119–124, 1984. the cytoplasmic tail of the integrin beta 3 subunit. J Cell Biol 131(3):807–816, 1995.
885. Chen K, Detwiler TC, Essex DW: Characterization of protein disulphide isomerase 918. Shock DD, et al: Calcium-dependent properties of CIB binding to the integrin
released from activated platelets. Br J Haematol 90(2):425–431, 1995. alphaIIb cytoplasmic domain and translocation to the platelet cytoskeleton. Biochem
886. Essex DW, Chen K, Swiatkowska M: Localization of protein disulfide isomerase to the J 342(Pt 3):729–735, 1999.
external surface of the platelet plasma membrane. Blood 86(6):2168–2173, 1995. 919. Zent R, et al: Class- and splice variant-specific association of CD98 with integrin beta
887. Essex DW, Li M: Redox control of platelet aggregation. Biochemistry 42(1):129–136, cytoplasmic domains. J Biol Chem 275(7):5059–5064, 2000.
2003. 920. Naik UP, Eckfeld K: Junctional adhesion molecule 1 (JAM-1). J Biol Regul Homeost
888. Mor-Cohen R, et al: Disulfide bond exchanges in integrins alphaIIbbeta3 and Agents 17(4):341–347, 2003.
alphavbeta3 are required for activation and post-ligation signaling during clot retrac- 921. Ming Z, et al: Lyn and PECAM-1 function as interdependent inhibitors of platelet
tion. Thromb Res 133(5):826–836, 2014. aggregation. Blood 117(14):3903–3906, 2011.
889. O’Neill S, et al: The platelet integrin alpha IIbbeta 3 has an endogenous thiol isomerase 922. Tourdot BE, et al: Immunoreceptor tyrosine-based inhibitory motif (ITIM)-
activity. J Biol Chem 275(47):36984–36990, 2000. mediated inhibitory signaling is regulated by sequential phosphorylation mediated by
890. Furie B, Flaumenhaft R: Thiol isomerases in thrombus formation. Circ Res distinct nonreceptor tyrosine kinases: A case study involving PECAM-1. Biochemistry
114(7):1162–1173, 2014. 52(15):2597–2608, 2013.
891. Wang L, et al: Platelet-derived ERp57 mediates platelet incorporation into a growing 923. Scarborough RM, et al: Design of potent and specific integrin antagonists. Peptide antag-
thrombus by regulation of the alphaIIbbeta3 integrin. Blood 122(22):3642–3650, 2013. onists with high specificity for glycoprotein IIb-IIIa. J Biol Chem 268:1066–1073, 1993.
892. Provasi D, Negri A, Coller BS, Filizola M: Talin-driven inside-out activation mech- 924. Beer JH, Springer KT, Coller BS: Immobilized Arg-Gly-Asp (RGD) peptides of vary-
anism of platelet αIIbβ3 integrin probed by multimicrosecond, all-atom molecular ing lengths as structural probes of the platelet GPIIb/IIIa receptor. Blood 79:117–128,
dynamics simulations. Proteins 82(12):3231–3240, 2014. 1992.
893. Gottschalk KE: A coiled-coil structure of the alphaIIbbeta3 integrin transmembrane 925. Luo BH, Springer TA, Takagi J: Stabilizing the open conformation of the integrin
and cytoplasmic domains in its resting state. Structure 13(5):703–712, 2005. headpiece with a glycan wedge increases affinity for ligand. Proc Natl Acad Sci U S A
894. Lau TL, Kim C, Ginsberg MH, Ulmer TS: The structure of the integrin alphaIIb- 100(5):2403–2408, 2003.
beta3 transmembrane complex explains integrin transmembrane signalling. EMBO 926. Heilmann E, et al: Thrombin-induced platelet aggregates have a dynamic structure:
J 28(9):1351–1361, 2009. Time-dependent redistribution of GPIIb/IIIa complexes and secreted adhesive pro-
895. Luo BH, Springer TA, Takagi J: A specific interface between integrin transmembrane teins. Arterioscler Thromb 11:704–718, 1991.
helices and affinity for ligand. PLoS Biol 2(6):776–786, 2004. 927. Isenberg WM, McEver RP, Phillips DR, et al: The platelet fibrinogen receptor: An
896. Wegener KL, et al: Structural basis of integrin activation by talin. Cell 128(1):171–182, immunogold-surface replica study of agonist-induced ligand binding and receptor
2007. clustering. J Cell Biol 104(6):1655–1663, 1987.
897. Hernandez-Campo PM, et al: Comparative analysis of different flow cytometry-based 928. Prevost N, Shattil SJ: Outside-in signaling by integrin αIIbβ3, in Platelets, edited by
immunophenotypic methods for the analysis of CD59 and CD55 expression on major AD Michelson, pp 347–350. Academic Press, San Diego, 2007.
peripheral blood cell subsets. Cytometry 50(3):191–201, 2002. 929. Asch E, Podack E: Vitronectin binds to activated human platelets and plays a role in
898. Robb L, et al: Molecular characterisation of mouse and human TSSC6: Evidence that platelet aggregation. J Clin Invest 85(5):1372–1378, 1990.
TSSC6 is a genuine member of the tetraspanin superfamily and is expressed specifi- 930. Haverstick DM, et al: Inhibition of platelet adhesion to fibronectin, fibrinogen,
cally in haematopoietic organs. Biochim Biophys Acta 1522(1):31–41, 2001. and von Willebrand factor substrates by a synthetic tetrapeptide derived from the
899. Hughes PE, et al: Breaking the integrin hinge. A defined structural constraint regu- cell-binding domain of fibronectin. Blood 66:946–952, 1990, 1985.
lates integrin signaling. J Biol Chem 271(12):6571–6574, 1996. 931. Plow EF, D’Souza SE, Ginsberg MH: Ligand binding to GPIIb-IIIa: A status report.
900. Anthis NJ, Wegener KL, Ye F, et al: The structure of an integrin/talin complex reveals Semin Thromb Hemost 18(3):324–332, 1992.
the basis of inside-out signal transduction. EMBO J 28(22):3623–3632, 2009. 932. Weiss HJ, et al: Fibrinogen-independent platelet adhesion and thrombus formation on
901. Ithychanda SS, Das M, Ma YQ, et al: Migfilin, a molecular switch in regulation of subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. J Clin
integrin activation. J Biol Chem 284(7):4713–4722, 2009. Invest 83:288–297, 1989.
902. Jenkins AL, et al: Tyrosine phosphorylation of the beta3 cytoplasmic domain mediates 933. Schullek J, Jordan J, Montgomery RR: Interaction of von Willebrand factor with
integrin-cytoskeletal interactions. J Biol Chem 273(22):13878–13885, 1998. human platelets in the plasma milieu. J Clin Invest 73:421–428, 1984.
903. Jones CI, et al: Integrin-linked kinase regulates the rate of platelet activation and is 934. Ni H, et al: Persistence of platelet thrombus formation in arterioles of mice lacking
essential for the formation of stable thrombi. J Thromb Haemost 12(8):1342–1352, both von Willebrand factor and fibrinogen. J Clin Invest 106(3):385–392, 2000.
2014. 935. Ni H, et al: Control of thrombus embolization and fibronectin internalization by
904. Calderwood DA, Shattil SJ, Ginsberg MH: Integrins and actin filaments: Reciprocal integrin alpha IIb beta 3 engagement of the fibrinogen gamma chain. Blood 102(10):
regulation of cell adhesion and signaling. J Biol Chem 275(30):22607–22610, 2000. 3609–3614, 2003.

Kaushansky_chapter 112_p1829-1914.indd 1899 17/09/15 3:30 pm